These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14979907)

  • 21. Multistep tumorigenesis and the microenvironment.
    Schedin P; Elias A
    Breast Cancer Res; 2004; 6(2):93-101. PubMed ID: 14979914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
    Nuyten DS; van de Vijver MJ
    Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarrays bring new insights into understanding of breast cancer metastasis to bone.
    Welch DR
    Breast Cancer Res; 2004; 6(2):61-4. PubMed ID: 14979907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
    Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
    J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.
    Lawler K; Papouli E; Naceur-Lombardelli C; Mera A; Ougham K; Tutt A; Kimbung S; Hedenfalk I; Zhan J; Zhang H; Buus R; Dowsett M; Ng T; Pinder SE; Parker P; Holmberg L; Gillett CE; Grigoriadis A; Purushotham A
    Breast Cancer Res; 2017 Oct; 19(1):113. PubMed ID: 29029636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.
    Dat le T; Matsuo T; Yoshimaru T; Kakiuchi S; Goto H; Hanibuchi M; Kuramoto T; Nishioka Y; Sone S; Katagiri T
    Int J Oncol; 2012 May; 40(5):1455-69. PubMed ID: 22294041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel gene expression signature for bone metastasis in breast carcinomas.
    Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
    Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
    Xia TS; Wang GZ; Ding Q; Liu XA; Zhou WB; Zhang YF; Zha XM; Du Q; Ni XJ; Wang J; Miao SY; Wang S
    Breast Cancer Res Treat; 2012 Apr; 132(2):471-86. PubMed ID: 21638054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of Bacteria from Virus Sensitivity to Virus Resistance.
    Luria SE; Delbrück M
    Genetics; 1943 Nov; 28(6):491-511. PubMed ID: 17247100
    [No Abstract]   [Full Text] [Related]  

  • 30. Road map to metastasis.
    Van't Veer LJ; Weigelt B
    Nat Med; 2003 Aug; 9(8):999-1000. PubMed ID: 12894162
    [No Abstract]   [Full Text] [Related]  

  • 31. Metastasis suppressor pathways--an evolving paradigm.
    Shevde LA; Welch DR
    Cancer Lett; 2003 Jul; 198(1):1-20. PubMed ID: 12893425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multigenic program mediating breast cancer metastasis to bone.
    Kang Y; Siegel PM; Shu W; Drobnjak M; Kakonen SM; Cordón-Cardo C; Guise TA; Massagué J
    Cancer Cell; 2003 Jun; 3(6):537-49. PubMed ID: 12842083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?
    Hynes RO
    Cell; 2003 Jun; 113(7):821-3. PubMed ID: 12837240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic background is an important determinant of metastatic potential.
    Hunter K; Welch DR; Liu ET
    Nat Genet; 2003 May; 34(1):23-4; author reply 25. PubMed ID: 12721549
    [No Abstract]   [Full Text] [Related]  

  • 35. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population.
    Fidler IJ; Kripke ML
    Nat Genet; 2003 May; 34(1):23; author reply 25. PubMed ID: 12721548
    [No Abstract]   [Full Text] [Related]  

  • 36. Metastasis suppressors alter the signal transduction of cancer cells.
    Steeg PS
    Nat Rev Cancer; 2003 Jan; 3(1):55-63. PubMed ID: 12509767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A gene-expression signature as a predictor of survival in breast cancer.
    van de Vijver MJ; He YD; van't Veer LJ; Dai H; Hart AA; Voskuil DW; Schreiber GJ; Peterse JL; Roberts C; Marton MJ; Parrish M; Atsma D; Witteveen A; Glas A; Delahaye L; van der Velde T; Bartelink H; Rodenhuis S; Rutgers ET; Friend SH; Bernards R
    N Engl J Med; 2002 Dec; 347(25):1999-2009. PubMed ID: 12490681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecular signature of metastasis in primary solid tumors.
    Ramaswamy S; Ross KN; Lander ES; Golub TR
    Nat Genet; 2003 Jan; 33(1):49-54. PubMed ID: 12469122
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.